Journal article
Healthcare Utilization and Costs Associated with Different Treatment Protocols for Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Population-Based Study
Abstract
BACKGROUND: Though cooperative trial groups use different treatment protocols for newly diagnosed childhood acute lymphoblastic leukemia (ALL), all achieve high cure rates. The healthcare utilization and costs associated with different treatment strategies have not been rigorously compared. Minimizing utilization and costs may increase quality of life and decrease health system burden. We compared Children's Oncology Group (COG) and Dana-Farber …
Authors
Gupta S; Mittman N; Pechlivanoglou P; Li Q; Athale U; Bassal M; Breakey VR; Gibson PJ; Silva M; Zabih V
Journal
Blood, Vol. 136, No. Supplement 1, pp. 46–47
Publisher
American Society of Hematology
Publication Date
November 5, 2020
DOI
10.1182/blood-2020-136365
ISSN
0006-4971